IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Lion Point Capital, LP

Q2 2023 Holdings

Filed 2023-08-14 | 30 holdings | $221.3M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Semtech Corp(SMTC)CallCOM816850101$63.7M2,500,00028.8%
Semtech Corp(SMTC)COM816850101$62.4M2,452,85528.2%
Marinus Pharmaceuticals Inc(MRNS*)COM NEW56854Q200$24.5M2,257,52111.1%
Spdr S&P 500 ETF TR(SPY)PutTR UNIT78462F103$22.2M50,00010.0%
Chord Energy Corporation(CHRD)COM NEW674215207$15.7M102,4037.1%
Ardelyx Inc(ARDX)COM039697107$5.2M1,526,6672.3%
Burgerfi International Inc(0LS)COM12122L101$4.3M2,745,9381.9%
Seres Therapeutics Inc(MCRB1EUR)COM81750R102$3.3M691,8031.5%
Durect Corp(DC8A)COM NEW266605500$3.0M601,6641.3%
Battalion Oil Corp(BATL)COM07134L107$2.2M380,8911.0%
Kiniksa Pharmaceuticals LTDCOM CL AG5269C101$1.8M130,6910.8%
Bluebird BIO IncCOM09609G100$1.7M531,2560.8%
Milestone Pharmaceuticals in(MIST)COM59935V107$1.3M450,2070.6%
Aclaris Therapeutics Inc(ACRS)COM00461U105$1.1M109,8980.5%
2Seventy BIO Inc(TSVT*)COMMON STOCK901384107$1.1M111,6670.5%
Cymabay Therapeutics Inc(CBAYUSD)COM23257D103$1.1M99,4250.5%
Insmed Inc(INSM)COM PAR $.01457669307$1.1M50,3350.5%
Fennec Pharmaceuticals Inc(FENC)COM31447P100$971.3K110,0000.4%
Horizon Therapeutics PUB LSHSG46188101$761.1K7,4000.3%
Syndax Pharmaceuticals Inc(SNDX)COM87164F105$722.1K34,5000.3%
Mirum Pharmaceuticals Inc(MIRM)COM604749101$698.5K27,0000.3%
Aadi Bioscience Inc(WHWK)COM00032Q104$563.8K82,4230.3%
Mersana Therapeutics IncCallCOM59045L106$480.3K146,0000.2%
Origin Materials Inc(ORGN)COM68622D106$426.0K100,0000.2%
Harpoon Therapeutics IncCOM41358P106$324.1K456,5140.1%
Burgerfi International IncCall*W EXP 12/16/20212122L119$265.6K2,083,4380.1%
Lumos Pharma IncCOM55028X109$258.6K78,3510.1%
Microsoft Corp(MSFT)COM594918104$34.1K1000.0%
Alphabet Inc(GOOG)CAP STK CL C02079K107$12.1K1000.0%
PDC Energy Inc(PDCEUSD)COM69327R101$7.1K1000.0%